Contigo Compounding
⚠ Prototype — verify licensure and accreditation directly before publishing.
Contigo Compounding is a 503A compounding pharmacy. In-house 503A pharmacy acquired by Eden Health (Aug 2025) for vertically-integrated fulfillment. Referenced by: Eden Health (in-house).
What "503A" means
A 503A pharmacy is state-licensed and compounds for individual patients under patient-specific prescriptions, following USP <797> sterile-compounding standards. It is inspected by the state board of pharmacy. Neither tier produces an FDA-approved product. See our 503A vs 503B explainer.
How to verify Contigo Compounding
- Look up the pharmacy's license on its state board of pharmacy registry.
- Check FDA's registered outsourcing facilities list if it claims 503B status.
- Confirm the telehealth provider actually names Contigo Compounding as its fulfillment pharmacy.
- Run the provider through our verification checklist.
Independent & transparent
This website is independently operated and is not owned by, affiliated with, or paid by any provider listed. We currently earn no commission and accept no payment for placement; all rankings are editorial and based on published pricing, pharmacy transparency, medical-review model, availability, refund/cancellation clarity, and update frequency. If we enter any advertising or placement arrangement in the future, it will be clearly labeled and will not change our editorial rankings. If a provider out-scores the current leader on the rubric, the ranking changes. See our methodology → · Who pays us →